Syneos Health: Q3 Earnings Insights

 

Shares of Syneos Health SYNH moved higher by 3.2% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share increased 19.54% year over year to $1.04, which beat the estimate of $0.90.

Revenue of $1,099,000,000 decreased by 6.63% year over year, which missed the estimate of $1,120,000,000.

Outlook

The upcoming fiscal year's revenue expected to be between $4,900,000,000 and $5,100,000,000.

Conference Call Details

Date: Oct 29, 2020

Time: 08:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/5gaeoxvd

Recent Stock Performance

52-week high: $74.25

Company's 52-week low was at $30.02

Price action over last quarter: down 13.62%

Company Overview

Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNews
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!